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Aim.Physicochemicalmechanicalandinvitrobiologicalpropertiesofnovelformulationsofpolymericcalciumphosphatecements
(CPCs) were investigated. Methods. Monocalcium phosphate, calcium oxide, and synthetic hydroxyapatite were combined with
either modiﬁed polyacrylic acid, light activated polyalkenoic acid, or polymethyl vinyl ether maleic acid to obtain Types I,
II, and III CPCs. Setting time, compressive and diametral strength of CPCs was compared with zinc polycarboxylate cement
(control). Specimens were characterized using X-ray diﬀraction, scanning electron microscopy, and infrared spectroscopy. In vitro
cytotoxicity of CPCs and control was assessed. Results. X-ray diﬀraction analysis showed hydroxyapatite, monetite, and brushite.
Acid-basereactionwasconﬁrmedbytheappearanceofstretchingpeaksinIRspectraofsetcements.SEMrevealedrod-likecrystals
and platy crystals. Setting time of cements was 5–12min. Type III showed signiﬁcantly higher strength values compared to control.
Type III yielded high biocompatibility. Conclusions. Type III CPCs show promise for dental applications.
1.Introduction
The rapidly evolving ﬁeld of materials science is providing
dentistry with new treatments and alternatives. Calcium
phosphate materials have been increasingly employed in
orthopedicanddentalapplications.Recently,muchattention
has been paid to calcium phosphate cements (CPCs) because
of their advantages in comparison with calcium phosphate
bioceramics, regarding in situ handling and shaping abilities
[1, 2]. The CPCs are obtained by an acid-base reaction
in water between an acidic calcium phosphate and a
basic calcium phosphate, giving an intermediate basicity
calcium phosphate that precipitates [3]. The use of CPCs
with their biocompatibility, potential for osteoconduction
and seal-ing ability, may improve the prognosis of dental
treat-ment. In this regard, CPCs have been explored for
the treatment of furcal exposures [4], root sensitivity, open-
root apices, and endodontic obturation [5, 6]. The self-
setting and biocompatibility properties of CPCs suggest that
they would be superior to pure calcium hydroxide. Thus,
these materials may have utility for dentine regeneration,
pulp capping, and cavity lining [7, 8]. In addition, instead of
pure CPC, composites fabricated from calcium phosphates
and polymers may have applications as pulp capping and
cavity-basing materials [9]. Finally, the release of ions (OH−,
PO4
−3,a n dC a +2) from cements with a Ca/P ratio of 1.67
has been reported to have antimicrobial properties. Despite
these potential advantages, the usefulness of water-based
CPC pastes are limited, since under ambient conditions,
they are not highly cohesive and vulnerable to wash out
until hardening occurs [10]. Therefore, modifying additives
like calcium chloride and sodium alginate were tried as2 International Journal of Biomaterials
reinforcing materials [11]. In studies on CPCs, sodium
alginateorcellulosederivativesdissolvedinthecementliquid
was suggested for improving the cohesion of CPC pastes.
CPCs exhibit relatively low mechanical strength, mechanical
properties are relatively weak compared to enamel, dentin,
resin-based composites and some dental cements [12].
Moreover, in the present state, CPCs do not compare
favorably with currently available dental cements in terms of
settingtime.Therefore,modiﬁcationofpowdercomposition
andproperties,introductionofreinforcingmaterialsintoliq-
uids, and/or changing the mixing methods are necessary for
improvements of CPCs to meet the requirements for dental
applications, and thus replace calcium hydroxide pastes cur-
rently used in dentistry with more durable materials bearing
setting time (2–8) minutes and a high compressive strength
(50–80MPa) while retaining their biological advantages.
In this study, we tested the hypothesis that incorporation
of several polymeric acids into traditional CPCs would pro-
duce formulations with promising physical, mechanical and
biological properties to permit wide dental applications. The
present study tests this hypothesis by measuring: (1) the
physical chemical characteristics of three novel CPC for-
mulations derived from a mixture of CPC powder with three
aqueous solutions of polymeric acids (modiﬁed polyacrylic
acid, light-activated modiﬁed polyalkenoic acid, and 35%
w/w polymethyl vinyl ether maleic acid as compared to a
clinically available zinc polycarboxylate cement, (2) the com-
pressive and diametral tensile strength of these polymeric
cements, and (3) using the direct contact cell culture format,
we compare the cytotoxic properties of these CPC formu-
lations and one clinically available zinc polycarboxylate
cement. (The biocompatibility examined on human gingival
ﬁbroblast cells and the cell viability quantiﬁed using MTT
assay.)
2.MaterialsandMethods
Three polymeric calcium phosphate cements and zinc poly-
carboxylate cement were evaluated (Table 1). The powder
component of the calcium phosphate cements was derived
from a mixture of monocalcium phosphate monohydrate
(MCPM), calcium oxide (CaO), and synthetic hydroxyap-
atite(SHAp6).Threetypesofaqueoussolutionsofpolymeric
acids were used for mixing these powders to obtain novel
polymeric-CPC formulations.
2.1. Preparation of Calcium Phosphate Cement Powder. Both
the monocalcium phosphate monohydrate (MCPM) and
the calcium oxide (CaO) powder were crushed separately
in an agate mortar and then sieved to obtain an average
particle size of 80μm 0.074mm sieve was used (mesh size
no. 200). A mixture of MCPM and CaO was prepared at a
Ca/P ratio of 1:67 (same ratio present in bone and dentin)
[13]. This mixture constituted 60% of the total weight of
the powder. Synthetic hydroxyapatite (SHAp6) was chem-
ically precipitated using appropriate amount of Ca(OH)2
and concentrated phosphoric acid to maintain Ca/P ratio
of 1.67. Synthetic hydroxyapatite (SHAp6) (40wt%) was
incorporated to increase the ultimate strength of the cement
and to act as seeds for nucleation of more hydroxyapatite
[14, 15]. The powder was mechanically mixed in a Turbula
shaking apparatus (Willy Bachofen, Basel, Switzerland).
2.2. Preparation of Aqueous Solution of Polymeric Liquids.
Three types of polymeric liquids (Table 1) were mixed indi-
vidually with the calcium phosphate powder: (1) modiﬁed
polyacrylic acid of zinc polycarboxylate cement (Type I
cement), (2) visible light-cured modiﬁed-polyalkenoic acid
of glass ionomer as supplied by manufacturer (Type II
cement), and (3) a 35% (w/w) aqueous solution of poly-
methyl vinyl ether maleic acid, prepared by dissolving 35g
of the white powder of polymethyl vinyl ether maleic anhy-
dride (PMVE-MA) copolymer (molecular weight 50,000) in
100mL of distilled water. The 35% w/w aqueous solution
of PMVE-Ma was mixed with CPC powder to form the
polymeric-CPC cement (Type III cement).
2.3. Preparation of Polymeric CPC Cements. Several pilot
studies were performed to select the best powder to liquid
ratio (4:1) that produced good handling characteristics
and working time. Zinc polycarboxylate cement was mixed
according to the manufacturer’s instructions and considered
as an additional control group. These newly formulated
calcium phosphate cements composed of one form of
powder and three diﬀerent types of liquid were evaluated
and compared to the control group (zinc polycarboxylate)
cement in regards to the following.
2.4. Determination of Setting Time. The initial setting time
of each of the cement mixtures under investigation was
determined according to the method described in the
ANSI/ASTM-C-191-1977 [16, 17] using Gillmore needle
(Zur nadel-Ton Industries, Berlin, Germany) (113.4gm. and
diameter 2.13mm). The initial setting time was determined
as the time elapsed from the start of mixing until the needle
fails to leave an indentation deeper than 1mm on the cement
surface. The setting time was recorded to the nearest minute
and the test was repeated ﬁve times. The mean and standard
deviation for both the experimental and the commercial zinc
polycarboxylate cement were calculated.
2.5. Assessment of the Mechanical Properties of
the Prepared Cements
(a) Preparation of the Compressive Strength Test Specimens.
A total of 120 cylindrical specimens of 6mm diameter and
12mm height were prepared according to the ISO speci-
ﬁcation no. 4104 [18] for zinc polycarboxylate cement.
The cement pastes were mixed as previously described
and inserted into a split metal mold. For the visible light
cured version of polymeric CPC, special Teﬂon mould was
used, and the material was built up in small increments.
Each increment was light cured for 60s from each side
with a composite curing unit with an output of at least
500MWcm−2 (Kulzer Translux CL, Wehrheim,Germany).International Journal of Biomaterials 3
Table 1: Materials used in this study and their manufacturers.
Material Composition Trade Name Manufacturers
(1) Zinc polycarboxylate
cement
Powder: Zinc oxide with traces of Mg
oxide and Sn oxide.
Liquid: aqueous solution of polyacrylic
acid and in taconic acid.
G.C.R. Advanced Research IncDental
division England
(2) Glass Ionomer liquid light
cured modiﬁed polyalkenoic
acid
A light sensitive aqueous solution of
polyalkenoic acid modiﬁed with
methacrylic group.
Vitremer 3M Dental products St. Louis,
USA
(3) Monocalcium phosphate
monobasic (MCPM)
Calcium Phosphate
Monobasic
Sigma Chemical Co., Aldrich
GmbhGermany
(4) Calcium oxide (CaO) Adwic Laboratory Chemical
(5) Polymethyl vinyl ether
maleic anhydrate copolymer
(white powder) PMVE-Ma
Sigma-chemical Laboratories St.
Louis, USA
(6) Synthetic hydroxylapatite
(SHAP6)
Prepared at the Department of
Dental Materials of the Medical
College of Georgia, Augusta, Ga,
USA
The split molds were covered with glass plates, and speci-
mens were kept undisturbed for 60 minutes at 37◦Cu n d e r
100% relative humidity before separation from the mould
[19]. The specimens were immersed in distilled water for 1
hour, 24hr, 1 week, 4 weeks, and 8 weeks before the com-
pressive strengths were measured. Each specimen was placed
in 5mL of distilled water. The distilled water was renewed
every week.
(b) Preparation of the Diametral Tensile Strength Specimens.
For the diametral tensile strength test, 120 disc specimens of
6mmdiameterand3mmheightwerepreparedforeachtype
of cement [20]. The specimens were prepared as previously
described for the compressive strength test.
(c) Testing Procedure. The compressive and diametral tensile
strength test of each type of cement were determined after
1h o u r ,2 4h o u r s ,1w e e k ,4w e e k s ,a n d8w e e k ss t o r a g e
in distilled water using a Universal Testing Machine (Com-
Ten Industries, Inc., Fla, USA) at a cross-head speed of
0.5mm/min. The compressive strength was measured by
dividing the maximum load in compression on the ends of
the cylindrical specimens by the original cross-sectional area
ofthetestspecimen[21].Whilethediametraltensilestrength
(DTS) was calculated according to the equation (DTS =
2P/πDT), where P is the applied load, D is the diameter
of the cylinder, and T is the thickness of the specimen. A
sheet of ﬁlter paper (Whatman Type no. 1, Whatman inter-
national, Springﬁeld Mill, Maidstone, Kent, England) was
placed underneath, and another sheet was placed on the top
of the cement specimen during the loading.
A l ld a t ar e c o r d e dw e r es u b j e c t e dt oo n e - w a ya n a l y s i s
of variance (ANOVA) followed by (where appropriate) the
Tukey-B test to determine the level of signiﬁcance between
the experimental groups.
2.6. Infrared Spectroscopy Analysis (IR). Fragments of the set
cements used for the compressive strength test (24 hours
after mixing) were ground and weighed to obtain 1 gram of
each set material and were mixed with a measured amount
of potassium bromide in an agate mortar. After pressing the
mixtures into rigid pellets, IR analysis was performed using
a (Perkin Elmer IR spectrometer, Model 1403, USA) at a
wavelength range between 4000 and 600cm−1 [19, 20]. The
three types of polymeric liquids were also analyzed by IR
spectroscopy to obtain a base line reading.
2.7. Compositional Analysis. The CPC powder components
before and after mixing with the liquid and setting were
manually ground to a ﬁne powder in an agate mortar for
X-ray diﬀraction analysis (XRD) analysis. The XRD patterns
were collected on a theta-theta PANalytical X’Pert Pro X-
ray diﬀractometer. The instrument was scanned over a 5–
70◦ 2θ range with a 0.0167◦ step size and a dwell time of
99.695s/2.122◦ (2θ)f o rat o t a lm e a s u r e m e n tt i m eo f∼1hr .
A Ni-ﬁlter was used instead of a graphite monochromator to
block the kß radiation. The instrument was run at 45kV and
40mA.
Compound search-match identiﬁcation was performed
with jade soft ware (Version 9) from Materials Data Inc.
using the latest inorganic PDF4 powder diﬀraction data base
from the International Centre for Diﬀraction Data (ICDD).
2.8. Scanning Electron Microscopy. The evolution in mor-
phology of the crystalline structures formed during the pro-
cess of cement setting (24 hours after mixing) was observed
by examining the longitudinal and the fractured surface
of the samples using scanning electron microscopy (SEM)
(LEO 1450VP, Carl Zeiss SMT, Oberkochen, Germany).
2.9. Cell Culture Experiments. Sample preparation was per-
formed aseptically to prevent the risk of biological contam-
ination during the cytotoxicity testing [22]. Zinc polycar-
boxylate cement was prepared according to the manufac-
turer’s instructions.4 International Journal of Biomaterials
Six discs for eachcement (Types I, II, and III CPCs and
zincpolycarboxylatecement)werefabricatedinsterileTeﬂon
molds 5.5mm in diameter and 3mm thick. The materials
were packed into the mold and allowed to set at room
temperature (25◦C) before testing. Teﬂon discs were used as
an e g a t i v ec o n t r o l .
2.10. In Vitro Biological Testing. Specimens (n = 6) were
tested for in vitro cytotoxicity by placing them in direct con-
tact format (ISO10993) [23] using human gingival ﬁbro-
blast cells (HGFs) obtained from the Medical College of
Georgia School of Dentistry Clinics after obtaining approval
from the Medical College of Georgia Human Assurance
Committee. Primary cultures of HGFs were established from
healthy (noninﬂamed) tissue removed during routine surgi-
cal procedures, using a slight modiﬁcation of a previously
established protocol. Procedural details for this method have
been published elsewhere [24, 25]. Twenty-four hours prior
to the addition of the specimens, the cells were plated at 4
× 104/well in a 24-well format in 1mL of medium per well,
thenspecimenswereimmediately(<1min)addedtothecen-
ter of each well and secured such that the sample could not
move. The ratio of the surface area of the discs to the volume
of medium was within the range of 1.2mm2/mL as recom-
mended by the International Standards Organization. The
cells and specimens were incubated at 37◦C for 72 hours in
5% CO2, 95% air to allow attachment of the ﬁbroblasts to
the bottom of the wells. After this interval, the specimens
were removed from cell culture, rinsed twice with 18Mohm
sterile water, and stored in sterile phosphate buﬀered saline.
The entire set of experiments was repeated to assess the re-
producibility of the assay as applied to these materials. The
aging times were selected to extend intervals used and to
obtain an indication of the trend of cytotoxicity over time.
Cellular activity was assessed by measuring mitochon-
drial succinic dehydrogenase (SDH) activity via the MTT
colorimetric assay [26] after 1, 2, 3, and 4 weeks. Specimens
were removed from each well, and the remaining cells
were washed carefully with 1.0mL of phosphate-buﬀered
saline (pH 7.4). A 1mg/mL MTT solution [3-(4,5-dimethyl–
thiazol-2-yl-)-2,5-diphenyl tetrazolium bromide-succinate]
was added for 45min at 37◦C, after which the reaction
was quenched with the addition of 0.5mL of 4% Tris-for-
malin (pH 7.4) for 2-3min. The MTT-formalin solution was
removed, the cell monolayer was allowed to dry for 5–10
min then washedin 1.0mL of water,and any MTT-formazan
formed by SDH activity in the cells was solubilized with
6% dimethylsulfoxide-NaOH (0.1N NaOH in DMSO). An
aliquot of the resulting solution was transferred to a 96-well
ﬂat-bottomed tray, and the optical density was measured at
562nm, the absorption peak of the formazan. Six replicates
of each extract or control were performed in each test. Cyto-
toxicity was expressed as a percentage of the Teﬂon negative
control.
2.11. Statistical Analysis. For mitochondrial activity, the
meansandstandarddeviationsoftheMTT-formazanoptical
densities to Teﬂon controls were calculated. Statistical diﬀer-
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Figure 1: Histogram showing the mean compressive strength of
zinc polycarboxylate cement and the three polymeric CPCs in MPa.
ence between the calcium phosphates and the controls was
determined using analysis of variance (ANOVA) with Tukey
post hoc multiple comparison intervals (α = 0.05).
3. Results
3.1. Setting Time. The results of the initial setting time are
presented in (Table 2). The handling properties of polymeric
calcium phosphate cements were acceptable from the stand
point of working time.
3.2. Mechanical Properties. T h em e a nv a l u e so fc o m p r e s s i v e
strength and diametral tensile strength of zinc polycarboxy-
late cement (control group) and the three polymeric calcium
phosphate cements (Types I, II, and III) are listed in (Tables
3 and 4) and illustrated graphically in (Figures 1 and 2).
(a) Compressive Strength. At all the storage periods, from
1hr to 8 weeks, the compressive strength values of polymeric
calcium phosphate cement (Type III) derived from 35% w/w
aqueous solution of PMVE-Ma were higher than that of
zinc polycarboxylate cement (control) and the other two
polymeric calcium phosphate cements (P<0.05). The
mean compressive strength values of visible light cured
(VLC) polymeric CPC cement (Type II) were also higher
than that of zinc polycarboxylate cement (P<0.05). Type
I polymeric CPC showed the least compressive strength
values. When comparing the eﬀect of storage time on
the compressive strength of the individual cements, the
compressive strength of zinc polycarboxylate, signiﬁcantly
increased from 1 hour (46.85MPa) to 1 week (50.87MPa),
then signiﬁcantly increased up to 8 weeks (52.60MPa). The
mean value of compressive strength of (Type I) polymeric
CPC signiﬁcantly increased from 1 hour (40.42MPa) to 4
weeks (48.74MPa) then slightly decreased at the end of the
eighth week (46.91MPa).
The mean value of compressive strength of (Type II)
derived from visible light cured (VLC) polyalkenoic acid
slightly increased from 1 hour (66.86MPa) to one weekInternational Journal of Biomaterials 5
Table 2: The initial setting time (in minutes) of zinc polycarboxylate cement and the three polymeric calcium phosphate cements (CPCs).
Zinc polycarboxylate (control group) Polymeric calcium phosphate L.S.D.5%
Type I Type II Type II
Mean setting time (in minutes) ± SD 5 ± 15 ± 1— 9 ± 11 . 3 0 ∗
NB: Type II polymeric CPC (no setting reaction) VLC type.
∗Signiﬁcant at 5% level.
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Figure 2: Histogram showing the mean diametral strength of zinc
polycarboxylate cement and the three polymeric CPCs in MPa.
(67.15MPa) and remained nearly constant to the end of the
eighth week (67.12MPa).
The mean value of compressive strength of (Type III)
polymeric, CPC derived from (PMVE-Ma), signiﬁcantly
increased from 1 hour (71.68MPa) up to one week
(75.56MPa) then slightly decreased at the end of the eighth
week (73.59MPa).
(b) Diametral Tensile Strength. At all the storage periods
from 1 hour to 8 weeks, the mean diametral strength values
of polymeric calcium phosphate cement (Type III) and Type
(II)werehigherthanthatofzincpolycarboxylatecementand
(Type I) polymeric calcium phosphate cement (P<0.05).
When comparing the eﬀect of storage time on the mean
values of diametral tensile strength, zinc polycarboxylate
cement showed the highest diametral strength values at the
end of the ﬁrst week (4.49MPa) then gradually decreased at
the end of the eighth week.
The mean value of diametral tensile strength of (Type
I) polymeric CPC signiﬁcantly increased from 1 hour
(4.70MPa) up to one week (6.41MPa) then signiﬁcantly
decreased at the end of the eighth week (4.58MPa). The
mean diametral strength value of (Type II) polymeric cal-
cium phosphate cement signiﬁcantly increased from 1 hour
(7.39MPa)uptoone week(8.80MPa)and slightlydecreased
at the end of the eighth week (8.57MPa). The mean dia-
metral tensile strength value of (Type III) polymeric CPC
cement signiﬁcantly increased from 1 hour (11.43MPa) up
to one week (14.03MPa) then decreased at the end of the
eight week (12.59MPa).
3.3.InfraredSpectroscopicAnalysis. Theinfraredspectrumof
modiﬁed polyacrylic acid, visible light-cure modiﬁed poly-
alkenoic acid, 35% (w/w) aqueous solution of polymethyl-
vinylether-maleic acid (PMVE-Ma) and the set cements
derived from their mix with CPC powder are presented in
(Figures 3(A), 3(B), 3(C), and 3(D)).
The infrared spectrum of the modiﬁed PA acid
and the set zinc polycarboxylate cement (control group)
(Figure 3(A)) showed a stretching band at 1638cm−1,r e p -
resenting the (–C=O) antisymmetric stretching band of the
carboxylate group in the polyacrylic acid (Figure 3(A)). The
set product of zinc polycarboxylate cement (control group)
showed two IR-absorption bands at 1558 and 1418cm−1,
(Figure 3(B)) which were assigned to a carboxylic acid salts
(–COO) [27, 28].
The infrared spectrum of the modiﬁed PA acid and the
set cement (Type I) (Figure 3(B)) showed a stretching band
at 1638cm−1 representing the carboxylic group (–C=O)
of the polyacrylic acid (Figure 3(A)). The set products of
modiﬁed polyacrylic acid and CPC powder (Type I) showed
the disappearance of the stretching band at 1638cm−1 and
two other stretching bands appeared at 1558 and 1418cm−1,
indicating carboxylate salts formation (Figure 3(B)) [27,
28]. The infrared spectra of the light-sensitive modiﬁed
polyalkenoic acid and the set cement (Type II) (Figure 3(C))
showed a stretching absorption band at 1640cm−1,r e p -
resenting the carboxylic group (–C=O) of the modiﬁed
polyalkenoic acid (Figure 3(A)). The set products of the VLC
modiﬁed polyalkenoic acid and the CPC powder showed
the disappearance of the stretching band at 1640cm−1,a n d
two other stretching bands appeared at 1558 and 1418cm−1,
indicating carboxylate salt formation (–COO) (Figure 3(B))
[27, 28].
The infrared spectra of the 35% w/w aqueous solution
of PMVE-Ma acid and the set cement (Type III) are
shown in (Figure 3(D)). The (–C=O) stretching absorption
band of the carboxylic acid group of PMVE-Ma was
observed at1635cm−1 (Figure 3(A)).Thebandat1635cm−1
disappeared in the IR spectrum of the set cement and
two new stretching bands attributable to carboxylate (–
COO)formationwereobservedat1558cm−1 and1401cm−1
indicative of acid-base reactions involving PMVE-Ma acid
and CPC powder (Figure 3(B)) [19].
3.4. X-Ray Diﬀraction Analysis. Two phases (zincite-ZnO
and cassiterite-SnO2) which exhibited the characteristic
peaks around 2θ = 36.253◦ and 2θ = 26.611◦,r e s p e c t i v e l y ,
were detected in the XRD patterns of unreacted and reacted
zinc polycarboxylate cement (Figure 4). The XRD patterns
forTypes I, II, and IIIcements (Figure 5) were basicallyiden-
tical with four phases. The four phases and the characteristic
peaks are as follows: hydroxyapatite (HA) [Ca5(PO4)3(OH),
2θ = 31.773◦], monetite [CaPO3(OH), 2θ = 30.189◦],6 International Journal of Biomaterials
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Figure 3: (A) Zinc polycarboxylate cement; (B) Type I; (C) Type II; (D) Type III. For all cements tested, IR spectra of polymeric acids
(modiﬁed polyacrylic acid, modiﬁed polyalkenoic acid, 35% w/w aqueous solution of PMVE-Ma (a) showed the absorption bands of car-
boxylic group (C=O) between 1635 to 1640cm−1 cm (arrows). IR spectra of set cements (b) showed the absorption bands between 1558 and
1401cm−1 indicating the formation of carboxylic salts (arrows).
brushite [CaPO3(OH)·2H2O, 2θ = 11.681◦ and 20.934◦],
and calcite [CaCO3,2 θ = 29.400◦].
3.5. Scanning Electron Microscopy. The SEM photomicro-
graphs in (Figures 6(a) and 6(b)) of the surface topography
showed a porous surface with linear microcracks for both
zinc polycarboxylate (control) and Type I CPC cements.
A mixture of thin needle- or rod-shaped microcrystals
characteristic of hydroxyapatite were identiﬁed on the top
surface of Type II cement. These hydroxyapatite crystals were
precipitated on the cement surface together with plate-like
crystals as shown in (Figure 6(c)) .T h et o ps u rf a c eo fT ypeI I I
as shown in (Figure 6(d)) exhibited ﬂakes and sandy grain-
shaped crystals. The SEM examination of the longitudinal
fracture surface of zinc polycarboxylate and Type I cement
showed the same porous pattern formed of small and large
micropores and diﬀerent sized shallow cavities (Figures 7(a)
and 7(b)). Particles of Type II and Type III cements were
mostly clustered into agglomerates that locally exhibited
platy like crystals on their fracture surfaces (Figures 7(c) and
7(d)).
3.6. Cellular Mitochondrial Activity. Cellular mitochondrial
suppression induced by the CPCs and zinc polycarboxylate
cement (control group) is illustrated in (Figure 8). Aging
inﬂuenced the mitochondrial suppression of all materials
except Type II, which suppressed mitochondrial activity
throughout the testing intervals. For each week, the com-
parison among all cement types was highly signiﬁcant (P<
0.01). Type III cement showed an increase in SDH activityInternational Journal of Biomaterials 7
Table 3: Mean compressive strength and standard deviation of zinc polycarboxylate cement and the three polymeric calcium phosphate
cements (CPCs) in MPa.
Cement types 1 hour 24 hours 1 week 4 weeks 8 weeks F-value
Control zinc polycarboxylate 46.85 ± 3.51 50.83 ± 4.50 50.87 ± 2.65 51.88 ± 2.80 52.60 ± 2.95 4.33∗
Calcium phosphate cements (CPCs)
Type I 40.42 ± 3.33 44.87 ± 3.25 49.80 ± 2.75 48.74 ± 2.80 46.91 ± 3.65 3.90∗
Type II 66.86 ± 1.38 67.13 ± 1.30 67.15 ± 1.38 67.20 ± 1.30 67.12 ± 1.22 1.74∗
Type III 71.68 ± 3.15 75.12 ± 3.55 75.56 ± 2.75 73.62 ± 2.95 73.59 ± 3.10 4.09∗
LSD 5% 3.81∗ 4.22∗ 3.19∗ 3.30∗ 3.32∗
∗Signiﬁcant at 5% level.
Table 4: Mean diametral tensile strength and standard deviation of zinc polycarboxylate cement and the three polymeric calcium phosphate
cements (CPCs) in MPa.
Cement types 1 hour 24 hours 1 week 4 weeks 8 weeks F-value
Control zinc polycarboxylate 5.65 ± 1.91 5.92 ± 2.35 4.49 ± 1.91 5.50 ± 1.99 4.80 ± 1.51 2.55∗
Calcium phosphate cements (CPCs)
Type I 4.70 ± 1.84 5.85 ± 2.41 6.41 ± 2.04 5.55 ± 2.36 4.58 ± 1.84 2.77∗
Type II 7.39 ± 1.99 8.74 ± 1.74 8.80 ± 2.02 8.63 ± 2.51 8.57 ± 2.96 2.96∗
Type III 11.43 ± 2.37 13.81 ± 2.22 14.03 ± 1.95 12.77 ± 1.89 12.59 ± 1.57 3.66∗
∗Signiﬁcant at 5 % level.
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Figure 4:(a)X-raydiﬀractionpatternofunreactedzincpolycarbo-
xylate powder. (b) X-ray diﬀraction pattern of set zinc polycarboxy-
late cement.
by (>90%) and was statistically equivalent to the negative
Teﬂon control after 1wk. Type III cement was signiﬁcantly
higher than the Teﬂon control at week 2 and week 4. Type I
cementwasseverelycytotoxic(>90%suppression)relativeto
Teﬂon controls, but signiﬁcantly (P< 0.05) improved were
statistically equivalent to the Teﬂon control after 4 weeks.
Type II cement did not change signiﬁcantly in cytotoxicity
over the entire four week evaluation. Type II cement was
signiﬁcantly (P>0.05) lower than Teﬂon control over the
entire four week evaluation period. Zinc polycarboxylate
cement also signiﬁcantly suppressed mitochondrial activity
throughoutthetestingbutshowedsomeimprovementbythe
fourth week.
4. Discussion
The most diﬃcult challenge in designing and manipulating
dental materials is being able to mimic the complex physical
and functional characteristics of natural tissues. Develop-
ment of a replacement material that either mimics natural
tissue properties and performance and/or one that is even-
tually resorbed and replaced by equivalent new tissue is the
ﬁnal goal of restorative dentistry.
Thus, hydroxyapatite (HA) materials combined with or-
ganic compounds are promising dentin replacing materials.
Various calcium phosphate derivatives, for example, hydrox-
yapatite (HA), tricalcium phosphate (TCP), octacalcium
phosphate (OCP), dicalcium phosphate (DCP), and mono-
calcium phosphate (MCPM) have been studied in the last
decade because of their biocompatibility, osteoconductivity,
and self-hardening properties which are desirable in a broad
range of dental and biomedical application [17, 29–31]. The
CPC cements derived from these compounds have high pH
and freely available calcium ions, and both factors stimulate
the precipitation of secondary dentin [32, 33].
In the present study, experiments have been undertaken
in order to develop some nontraditional dental cementing
materials. The principal compounds [synthetic hydroxya-
patite (SHAp6) and calcium oxide (CaO)] that have been
used, proved to have (as far as dentistry is concerned)
encouraging properties which will certainly open an avenue
forthematerialscientiststoovercomesomeofthedrawbacks
encountered with well known dental cements. In the pre-
sent study, all materials selected for the preparation of poly-
meric calcium phosphate cements: calcium oxide (CaO)
monocalcium phosphate monohydrate (MCPM), and syn-
t h e t i ch y d r o x y a p a t i t e( S H A p 6 )p o w d e r sa sw e l la sm o d i ﬁ e d
polymeric liquids (Polyacrylic acid “PA”), visible light cured
polyalkenoic acid (VLC), and polymethyl vinyl ether maleic
acid (PMVE-Ma), are all of medical grade, commercially
available, and have a well-established compatibility.8 International Journal of Biomaterials
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Figure 5: X-ray diﬀraction pattern of the three types of polymeric cements (Type I, Type II, and Type III CPCs). (A) Unreacted powder
component. (B) Set product of Type I cement. (C) Set product of Type II cement. (D) Set product of Type III cement. Diﬀerent arrows indi-
cating the characteristic peaks of the diﬀerent crystalline phases of the X-ray diﬀraction pattern; cross-hatched arrows indicate the crystal
phase of calcium hydrogen phosphate hydrate, black arrows portlandite, grey arrows hydroxyapatite, and gradient arrows calcite.
Calcium oxide (CaO) is known to react rapidly with
water and plays and important role in the hydration reaction
of the set cement (a linear relationship was found to exist
between the strength and the degree of hydration of dental
cements) [34].
As for monocalcium phosphate monohydrate (MCPM)
itisoftenusedastheacidcalciumphosphateinhydrauliccal-
cium phosphate formulations, butcommercialMCPM is not
pure, contains a small amount of orthophosphoric acid and
moisture, is consequently diﬃcult to mill, and the powder is
sticky and presents aggregates.
Because granularity inﬂuences the mechanical properties
of the hardened cement, it was, therefore, necessary to
premix MCPM with CaO before grinding it though a rapid
decrease in the amount of (MCPM) was observed during
mechanical grinding by a solid-solid reaction with CaO [35].
An essential parameter was also considered before mixing
these two essentials components by sieving each one of them
separately up to 80 microns. The reduction of particle size
was found to produce a substantial decrease of the setting
time and accelerated the hardening of the cement without
signiﬁcantly aﬀecting the ﬁnal strength attained [13].
Ginebra et al. (2004) stated that the cement cannot
be univocally related to the degree of reaction without
considering the microstructural features [36]. The sieved
monocalcium phosphate (MCPM) and the calcium oxide
(CaO) forming 60% by weight were then mixed at a ratio of
Ca/P of 1.67 similar to that present in dentin and bone. Syn-
thetic hydroxyapatite incorporated in the starting powder
(40% by weight) is the most stable compound precipitated
at the used Ca/P ratio of 1.67. Hydroxyapatite sintered at
high temperature resulted in large particle size that increases
the ultimate strength of the cement, which was found to
be proportional to the precipitated amount of dicalcium
phosphate dihydrate. When these formulated powders were
mixed with water, the resultant cement had good handling
characteristics but poor mechanical properties [37].
Therefore, in the present work, in order to overcome the
disadvantages of mixing with water, the aqueous solutions
of modiﬁed (polyacrylic acid, polyalkenoic (VLC) and poly-
methylvinyl ether maleic acid) were used. Their setting re-
actionwasfoundtobebiphasic,theﬁrststepduringthemix-
ing time, (MCPM) reacted with CaO immediately to give di-
calcium phosphate dihydrate (DCPD) which in the second
step, reacted more slowly with the remaining CaO to give
hydroxyapatite.
An essential criterion was also considered in relation
to the molecular weight and concentration of the aqueous
solutions used for mixing the powder, as higher molecular
weights tend to result in cements with shorter setting times
and a higher compressive, diametral, and biaxial ﬂexural
strengths than lower molecular weight counter parts [37].
The polymethyl vinyl ether maleic anhydride (PVME-
Ma) is a commercial copolymer oﬀered in several molecularInternational Journal of Biomaterials 9
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Figure 6: SEM microphotograph of the longitudinal top surface of the four types of cements. (a) Zinc polycarboxylate cement; (b) Type I;
(c) Type II; (d) Type III after setting.
weights and can be dissolved by hydrolysis of the anhydride
group in water to form the corresponding maleic acid co-
polymer (polymethyl vinyl ether maleic acid). This copoly-
mer has already a number of nondental applications in
hair sprays and surgical adhesives, which suggests potential
favorable biocompatibility for dental and other biomedical
uses [20]. Because it was diﬃcult to form workable cements
from more highly concentrated solutions of PMVE-Ma due
totheirhighviscosities,concentrationsabove30%cannotbe
investigated. However, aqueous solutions of higher concen-
trations are feasible using lower molecular weight PMVE-
Ma. In the present work, PMVE-Ma (50.000 molecular
weight) was used in an aqueous solution of 35% w/w [19].
Inordertooptimizethepowderliquidratioofthemixing
powder, extensive preliminary testing of various powder
mixtures ratios was performed resulting in the optimal ratio
of 4:1.
4.1. Setting Time. The setting time of zinc polycarboxylate
cement (control group) used in this study agreed with those
values previously reported in the literature (Table 2).
The setting time results of the three formulated poly-
meric cements (Table 2) indicated that Type I mixed with
modiﬁed polyacrylic acid showed a clinically acceptable sett-
ing time (5min) which is mainly attributed to an initial
hydration reaction between the starting cement powder and
the water content of the liquid, followed by the completion
stage, which is reached by the acid-base reaction and
subsequentformationofcarboxylatesaltsasconﬁrmedinthe
IR spectral data of the set cement (Figure 3(B)).
As for Type II polymeric CPC cement mixed with poly-
alkenoic acid (VLC), the setting time (Table 2) cannot be
recorded as the surface of the cement remained soft for
a long time attributed to inhibited polymerization of the
methacrylate group of the liquid, since no light curing was
applied to primarily activate the photoinitiator in the hydro-
xyethylmethacrylate (HEMA) group and the presence of a
residual nonfunctional carboxylic group which was observed
in the IR spectra of the set cement (Figure 3(C)).
In Type III CPC mixed with (PMVE-Ma acid), a setting
time of 9min was observed. This may be attributed to the
multifunctional nature of the PMVE-Ma acid which appears
to react forming insoluble products which coat the cement
particle. This encapsulation slightly retards their dissolution
which may be attributed to residual maleic anhydride units
as observed in the IR spectral data (Figure 3(D)) and sub-
sequent conversion to less soluble hydroxyapatite [19, 20].
4.2. Mechanical Properties. Results of the compressive and
diametral tensile strength values of the newly formulated
polymeric calcium phosphate cements (CPCs) as shown in10 International Journal of Biomaterials
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Figure 7: SEM microphotograph of the fractured surface of the four types of cements. (a) Zinc polycarboxylate cement; (b) Type I; (c) Type
II; (d) Type III after setting.
(Tables 3 and 4) denoted outstandingly improved values
when compared to zinc polycarboxylate cement (control
group). These high strength values may be attributed to
the synthetic hydroxyapatite which was incorporated in the
starting powder. Hydroxyapatite is known to increase the
strengthofthecementpowderandtoactasaseedfornuclea-
tion of more hydroxyapatite [38]. Yang et al. reported that
the seed concentration of (HA) improved crystallinity of the
apatite phase, thus increasing the compressive strength [39].
In this study, the reaction between CPC powder and 35%
(w/w) (PMVE-Ma) aqueous solution (Type III) resulted in
a polymeric CPC with a compressive strength of 71.68MPa
and diametral strength of 11.43MPa one hour after mixing.
These results are in accordance with Matsuya et al. [19].
These early strength values are very beneﬁcial and may
permit their use in certain clinical applications (temporary
ﬁllings, luting cements, and endodontic sealers). At the end
of the ﬁrst week, maximum strength values were reached.
This may be explained by the eﬀect of the molecular weight
of PMVE-Ma present in the liquid component is likely to
have inﬂuenced the compressive strength by virtue of the
reinforcement that can be provided by the elongated chains
of the polymer matrix. The high molecular weight (50,000)
of the PMVE-Ma, in addition to the highly branched struc-
ture, allows it to bridge numerous crystallites and engage
in intermolecular entanglements, providing strengthening
mechanisms.
The cement prepared from CPC powder and visible light
cure polyalkenoic acid (VLC) Type II had a compressive
strength value of 66.86MPa and diametral tensile strength of
7.39MPa, 1hr after mixing and reached its maximum value
at the end of 24 hours. These results coincide with Miyazaki
et al. [28]. The results were conﬁrmed by the IR analysis
of the reaction products, which showed that the reaction
has been completed as evident by the disappearance of the
stretching band (C=O) carboxylic group and the formation
of carboxylic salts. The compressive and tensile strength of
TypeII and TypeIII polymeric CPC weresigniﬁcantly higher
than that of zinc polycarboxylate (control group).
Storage in distilled water at 37◦C slightly aﬀected the
mechanical properties, therefore suggesting a stable formula
that can resist disintegration in the oral environment.
4.3. Setting Reactions. Multifunctional acids such as poly-
methylvinyl ether maleic acid (PMVE-Ma) and polyacrylic
acid (PA) are characterized by the presence of carboxylic
groups [21]. The calcium ions released from CPC powder
(MCPM and CaO) mainly react with the carboxylic group
of the polyacids and become cross-linked to the polyacid
chains by an ion exchange or an acid base reaction [20, 28].International Journal of Biomaterials 11
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Figure 8: Mitochondrial suppression induced by zinc polycarboxy-
late, Type I, Type II, and Type III calcium phosphate cements as
function of aging time. Cytotoxicity was measured by succinic de-
hydrogenase activity and expressed as a percentage of Teﬂon con-
trols (deﬁned as 100%). There were six replicates per condition.
Diﬀerentlettersindicateastatisticallysigniﬁcantdiﬀerencebetween
the materials (ANOVA, Tukey intervals α = 0.05).
This setting mechanism was previously described in other
types of polymeric calcium phosphate cements [27]. The
amorphous reaction products (polysalts) derived from the
reactionofPMVE-MaacidandPAacidwiththeCPCpowder
form a cement matrix analogous to that formed in zinc poly-
carboxylate and glass ionomer cement [20, 40–42].
The use of total reﬂectance of infrared spectroscopy
makes it possible to monitor the setting reaction and the
transformation of the COOH group to COO groups.
The infrared spectra of the set polymeric CPC Types (I,
II, and III) 24 hours after mixing showed the absence of
the stretching peak of carboxylic group (–COOH) and the
appearance of two new carboxylate stretching peaks indicat-
ing the formation of the polyacrylic salts (Figures 3(A), 3(B),
3(C), and 3(D)).
4.4. X-Ray Diﬀraction. The X-ray diﬀraction analysis of zinc
polycarboxylate unreacted powder identiﬁed two crystalline
phases ZnO and SnO2. The presence of tin oxide depends
on the commercial cement initially used: it is present in
small quantities in some cements and not in others. No zinc
polycarboxylate reﬂections were seen, since this compound
is amorphous. Therefore, the cement must be a composite
of unreacted oxides ZnO (mainly) and SnO2 and the amor-
phous zinc polycarboxylate matrix resulting from the setting
reaction of these oxides with polyacrylic acid and water.
These results are in accordance with the core link structure
proposed for such cements [43]. The X-ray diﬀraction
analysis of the unreacted CPC powder identiﬁed four phases:
hydroxyapatite [Ca5(PO4)3(OH)], monocalcium phosphate
monobasic hydrate [Ca(H2PO4)2·H2O], calcite [CaCO3],
and portlandite [Ca(OH)2].
During the hydration of cements consisting of nominally
60wt % monocalcium phosphate monobasic and calcium
oxide and 40 wt% hydroxyapatite, two dibasic phosphate
compounds, (monetite and its dihydrate, brushite) were
identiﬁed in the sample. Monocalcium phosphate monoba-
sic (MCPM) reacted with excess water forming monetite
and/or brushite by
Ca(H2 PO)2 ·H2O+ H 2O −→ CaHPO4 (monetite)
+H 3PO4 +2 H 2O −→ Ca HPO4 ·2H2O (brushite).
(1)
Calcium oxide is very hygroscopic and readily converts to
hydroxide by reacting with water vapor in air. Portlandite in
turn absorbs CO2 from air forming calcite.
4.5. Cellular Mitochondrial Activity. Although mechanical
and physical properties are of great concern for dentin
regenerating pulp capping, lining, or base material, biocom-
patibility is another critical issue. The current study estab-
lished that 4 weeks aging of the developed formulations of
calcium phosphate cements may signiﬁcantly change their
ability to alter cellular function. However, the eﬀect was
not uniform for all formulations. Type I calcium phosphate
cement(CPC mixed with polyacrylic acid) showed less mito-
chondrial suppression with time. It is possible as cytotoxic
elements leached from the material, they either complexed
with other molecules in the medium or broke down into
smaller components, in each case rendering it less cytotoxic.
For Type II calcium phosphate cements mixed with
resin modiﬁed glass ionomer (Vitremer), suppressed cellular
activitywasongoing,suggestingthatleachingofcomponents
with biological liabilities remained even after 4 weeks of
aging. The Vitremer liquid is a light sensitive, aqueous solu-
tion of a modiﬁed polyalkenoic acid and contains 2 hydroxy
ethyl methacrylate (HEMA). In most dental resin modiﬁed
glassionomercements,HEMAisoftenusedasacomonomer
to render the resin modiﬁed polyacid compatible with water
[44, 45]. However, HEMA was believed to cause potential
cytotoxicity to the surrounding tissue if not completely poly-
merized. This may have led to a greater change in the pH
of the culture medium, resulting in more cellular damage
andrepresentedbythesuppressionofmitochondrialactivity.
Type III CPC mixed with aqueous solution of polymethyl
vinyl ether maleic acid, however, exhibited compatibility
equivalent to Teﬂon over the entire time period with the
exception of weeks 3 and 4 time points, where it is several
folds higher than Teﬂon. A stimulation of the metabolic
activity of the cells in culture by the Type III CPC after 4
weeks is not easily explained and warrants further investiga-
tion.Polymethylvinylethermaliceanhydride(PMVE-Ma)is
acommercialcopolymeroﬀeredinseveralmolecularweights
and can be dissolved by hydrolysis of the anhydride group
in water to form the corresponding maleic copolymer (poly
methyl vinyl ether maleic acid). This copolymer has already
a number of nondental applications including hair sprays,
and surgical adhesives, which suggests potential for favorable
biocompatibility for dental and other biomedical uses [19].12 International Journal of Biomaterials
We prepared the CPCs by mixing calcium oxide, calcium
phosphate monohydrate (MCPM), and synthetic hydrox-
yapatite. Calcium oxide (CaO) is known to react rapidly
with water and plays an important role in the strength and
degree of hydration of dental cements. As for monocalcium
phosphate monohydrate (MCPM), it is often used as the
acid-calcium in hydraulic calcium phosphate formulations.
Calcium phosphate biomaterials are thought to generally be
biologically well tolerated, because the main inorganic con-
stituentsofbone,hydroxyapatiteiscomprisedofcalciumand
phosphate [46, 47].
Interestingly, the cytotoxicity of the three diﬀerent for-
mulations is dependent on the composition of the polymeric
acid used for mixing. In our experimental design, cytotoxic-
ity was estimated by mitochondrial succinate dehydrogenase
activity (SDH) activity in the MTT assay and expressed as a
percentage of the Teﬂon negative control value (100%) being
equivalent to Teﬂon with no evident cytotoxicity.
On the other hand, the biocompatibility of zinc polycar-
boxylate cement (control group) has also been investigated.
Our data show that zinc polycarboxylate cement was the
mostcytotoxicofthetestedmaterialsinaccordancewithpre-
vious data [48, 49].
5. Conclusion
Type III CPC presented reasonable setting time, signiﬁcantly
higher compressive, and diametral tensile strengths when
compared to zinc polycarboxylate cement (control group).
By virtue of these characteristics coupled with its bio-
compatibility,TypeIIICPCcementshowspromisefordental
applications.
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